Recent Headlines
Within Biotechnology
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
National Brain Tumor Society Appoints Renowned Pediatric Oncologist as Chief Scientific Officer
National Brain Tumor Society names leading pediatric cancer expert, Dr. Susan Blaney, as new Chief Scientific Officer. - September 08, 2025 - National Brain Tumor Society
DDi added more AI Agents to enhance Regulatory Strategy, Planning, and Project Actions
DDi introduces AI Agents for Strategy, Planning, and Actions, including Regulatory Insights, Regulatory Impact, and Planning Agents. These tools provide compliance visibility, assess regulatory impacts, and optimize planning, enabling organizations to act with confidence and agility. - August 22, 2025 - DDi LLC
CABRI Fellowship Program Opens for Undergraduate Research Applicants
The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. - August 15, 2025 - Cayman Chemical Company
YOLO Immune Inc. Emerges from Stealth Mode
YOLO Immune Inc. has emerged from stealth mode to unveil its human-centric drug discovery process and to announce the promotion of its founding research team. YOLO Immune is a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases. The... - July 31, 2025 - YOLO Immune Inc
Phenotap, Inc. Receives Progr. Related Investment from Helmsley Charitable Trust to Advance Breakthrough Ketone Sensor Technology for People Living with Type 1 Diabetes
Phenotap, Inc. announced a $3 million investment to support the continued development and optimization of KetoTap™ Core, a novel enzymatic technology, to make it active and stable enough to be used as part of a continuous ketone sensor that can help prevent the occurrence of diabetic ketoacidosis (DKA) for people living with type 1 diabetes (T1D). - July 14, 2025 - Phenotap, Inc.
Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders
Chicago-based Alera Bio has launched with a mission to develop treatments for ultra-rare and neglected neurological disorders, especially in children. Combining scientific innovation with patient urgency, the company will pursue both novel and repurposed therapies via orphan drug and 505(b)(2) pathways. With a lean, capital-efficient model, Alera Bio aims to rapidly advance therapies that address critical gaps in care. - July 03, 2025 - Alera Bio
DDi’s Visu Regulatory Platform Now with AI-Powered Project Management & Impact Assessment
DDi enhances its Visu platform with AI-driven project management tools, offering increased efficiency, real-time insights, and risk mitigation for pharma, biotech, and medical device industries. - June 29, 2025 - DDi LLC
Locus FS Announces Executive Appointments and Strategic Market Focus
Biotechnology company strengthens market position with new board and sharper commercial focus in oil & gas, mining, agriculture and industrial/CPG. - June 26, 2025 - Locus Fermentation Solutions
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
MtoZ Biolabs Launches Precision Chemical Proteomics Analysis Service
Chemical proteomics analysis service combines synthetic chemistry, cell biology, and mass spectrometry to profile small molecule–protein interactions for target identification, mechanism studies, and off-target evaluation. MtoZ Biolabs provides a one-stop chemical proteomics analysis service featuring Orbitrap MS, advanced probe design, and AI-driven analysis, supporting hit validation, candidate de-risking, and mechanistic research with high resolution and biological relevance. - June 20, 2025 - MtoZ Biolabs
New RNA Category: Self-Amplifiying RNAs (saRNAs) Are Now Available for a Longer Expression Period
Self-amplifying RNAs (saRNAs) also called “Replicons” are the next generation of RNA vaccines. Their advantage over conventional mRNA vaccine platforms relies on the viral replication machinery, which amplifies the mRNA of the encoded gene of interest within target cells. - June 20, 2025 - OZ Biosciences
Hundreds of Cyclists to Ride Through Durham, NH, June 21–22, to Raise Funds for ALS Research
On June 21, hundreds of cyclists will ride through Durham, NH, as part of the Tri-State Trek—New England’s premier ALS fundraising bike ride. This inspiring event raises critical funds for the ALS Therapy Development Institute, a nonprofit biotech leading the charge in developing effective treatments for ALS. The Trek brings together local families, riders, and volunteers in a powerful show of support for those living with this devastating disease. - June 16, 2025 - ALS Therapy Development Institute
3rd Annual ALS 100 Hole Challenge Set for June 17, 2025, in Hartford, CT
On Tuesday, June 17, 2025, twenty-four passionate golfers will take on a marathon challenge—playing 100 holes of golf in a single day—to raise critical funds and awareness in the fight against ALS. The third annual ALS 100 Hole Challenge will take place at Keney Park Golf Course in... - June 09, 2025 - ALS Therapy Development Institute
H3Tech Welcomes Ruiban Coutinho as AI Healthtech Consultant
H3Tech, a healthcare technology and consulting firm, has appointed Ruiban Coutinho as AI Healthtech Consultant. With 14 years of experience in data analytics and business intelligence, Coutinho will leverage his expertise in AI, SAP BW/HANA, and Power BI to enhance H3Tech’s AI-driven healthcare solutions. - June 06, 2025 - H3Tech
No Collars, No Limits: HALO Chip Brings Real-Time GPS Tracking Under the Skin
HALO Technologies, Inc. has developed an implantable GPS microchip for pets and wildlife. Now in pre-launch, The HALO Chip offers discreet, real-time tracking without external devices. - May 28, 2025 - Halo Technologies Inc
Phytobiosomes by Costas Picadas
Henri Dunant Hospital proudly presents Costas Picadas: Phytobiosomes, a unique exhibition of prints and digital installations that opened on Monday, May 19, 2025, and runs through Tuesday, September 30, 2025. The internationally recognized New York-based art historian Dr. Thalia Vrachopoulos curated the exhibition. - May 22, 2025 - Costas Picadas
The New Gods of Medicine Summit Debuts in Cannes This June
Longevity Docs Presents: The New Gods of Medicine Summit Debuts in Cannes This June. - May 21, 2025 - Longevity Docs
Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)
Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed data analysis of its Phase II trial of its new ultrasound contrast agent, MVT-100, CardiSon, in echocardiography. In this study, 16 subjects received either the predicate agent Perflutren, or CardiSon,... - May 15, 2025 - Microvascular Therapeutics, Inc.
ReLiftMD Reports Over 2,000 Successful Patient Treatments -- Re•Lift Me™ One-Hour Facial Rejuvenation Procedures Deliver Decade-Younger Looks Under Local Anesthesia
ReLiftMD LLC is changing the aesthetic landscape with its novel Re•Lift Me™ minimally invasive, long-lasting facial rejuvenation procedures. These procedures enable individuals to achieve a naturally youthful appearance, looking up to ten years younger, through a simple, one-hour procedure performed under local anesthesia. - May 07, 2025 - ReLiftMD, LLC
Industry-First Platform Combines AI-Powered Simulation and Lab Testing for Faster Biodegradation Assessment
Aropha's Biodegradation Studio is transforming how product developers approach biodegradability testing. The new platform combines rapid, AI-powered simulation with accredited laboratory services. Users can manage and accelerate every stage of biodegradability testing — from virtual screening to lab validation —through one, centralized hub. The studio helps R&D teams cut costs, screen more chemicals, speed up development and bring biodegradable materials to market faster. - May 06, 2025 - Aropha
Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio
Vetirus Pharmaceuticals, a multinational company headquartered in Naples, Florida, and London, UK, announced its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. The acquisition was revealed at the 10th annual Animal Health, Nutrition, and Technology Innovation Europe. - April 30, 2025 - Vetirus Animal Health
Mirror Biologics Announces Publication of Clinical Results Showing Potential for Allo-Priming to Provide Broad Protection to Elderly from Respiratory Viral Infection
A new approach for pandemic preparedness and protection of the elderly from any type of respiratory viral infection. Five injections over two weeks provides possible universal viral protection without need for booster shots. - April 28, 2025 - Mirror Biologics, Inc.
Caris Life Sciences Collaborates with Meaningful Insights Biotech Analytics (MiBA) to Advance Oncology Education and Quality of Care
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic collaboration with MiBA, an innovative healthcare technology company to provide physician education and insights to accelerate research, identify and... - April 24, 2025 - MiBA
Parvus Announces Achievement of First Milestone from its Collaboration Agreement with AbbVie to Develop IBD Therapies Based on the Parvus Nanomedicine Platform Technology
IND-enabling nonclinical and manufacturing activities executed by Parvus met prospective criteria resulting in the first milestone payment from AbbVie. - April 21, 2025 - Parvus Therapeutics U.S., Inc.
Minus K Congratulates to the following winners of their 2024/2025 Educational Giveaway
Celebrating its’ tenth year of their U.S. Educational Giveaway, Minus K Technology has to-date granted over $100,000 of its superior performing patented Negative-Stiffness low-frequency passive mechanical vibration isolators to colleges and universities in the USA. - April 03, 2025 - Minus K Technology Inc.
Apeximmune Therapeutics Announces Successful Close of Series A Fundraising Round to Advance Next-Generation Immunotherapies
Apeximmune Therapeutics, a biotechnology company pioneering next-generation immunotherapies, today announced the successful close of its Series A financing round, raising $21.3 million, exceeding its original goal of $20 million. The funding was led by PharmaEssentia Corporation, with participation... - April 01, 2025 - Apeximmune Therapeutics
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
Dr. Mike Chan: Leading the Future of Organ-Specific Stem Cell Therapies with Revolutionary Treatments in Regenerative Medicine
Dr. Mike Chan is a global leader in regenerative medicine, transforming lives with stem cells, exosomes, and peptides. His innovative treatments regenerate tissues, restore healing, and enhance vitality. Patients experience renewed hope, improved energy, and recovery from chronic conditions. His groundbreaking work is reshaping the future of healthcare. - March 28, 2025 - Dr. Mike Chan
Thar Process and Clean Heat Technologies Integrate CO2 Heat Pump Technology to Make Supercritical CO2 Technology a Low Cost Solution
Thar Process and Clean Heat Technologies have successfully engineered, integrated and installed electric heat pumps using CO2 - R744 - as the upcycled, natural refrigerant. The technology partnership means that Thar Process' clients can benefit from lower operating costs. Thar is known for it's innovative use of CO2 for extracting flavors, fragrances, medicinal and therapeutic compounds both in it's GMP certified facility in Pittsburgh and at client sites globally. - March 24, 2025 - Thar Process
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of hard-to-treat cancers. In combination with standard-of-care chemotherapy, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, prevents cancer recurrence, improves complete response rate and survival in experimental pancreatic cancer. In combination with anti-PD-L1 treatment, it overcomes pancreatic cancer resistance to immunotherapy. - March 21, 2025 - SignaBlok, Inc.
SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug at the Respiratory Innovation Summit and American Thoracic Society International Conference 2025
SignaBlok will present positive preclinical data on targeting innate inflammation for the treatment of sepsis and pulmonary diseases. In experimental sepsis, SignaBlok's new mechanism-based inhibitor of TREM-1, an inflammation amplifier, protects from death with the level of protection not declining at delayed treatment times. In pulmonary inflammation and fibrosis in rats and mice, it reduces neutrophil infiltration in the lungs and reverses fibrosis. - March 21, 2025 - SignaBlok, Inc.
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
ConductScience Accepted Into NVIDIA Connect Program, Advancing AI-Driven Behavioral Neuroscience Research Solutions
ConductScience joins the NVIDIA Connect program, accelerating AI advancements in behavioral research. This collaboration enhances ConductVision, ConductInsecta, ConductNest, and GaitMaster, optimizing research on locomotion, cognition, and social behavior across species. With NVIDIA’s support, ConductScience gains access to GPU-accelerated computing, engineering resources, and training, driving innovation in neuroscience, genetics, and medicine. - March 16, 2025 - ConductScience
Cenmed and ENG Scientific Partner to Deliver High-Quality Kitting and Custom Chemical Filling Solutions
Cenmed Enterprises and ENG Scientific have expanded their partnership to enhance kitting and custom chemical filling services for laboratories, biotech companies, and healthcare institutions. By combining Cenmed’s supply chain expertise with ENG’s chemical formulation capabilities, the collaboration streamlines reagent kit production, specimen collection solutions, and bulk chemical filling. This partnership strengthens Cenmed’s ability to deliver efficient, compliant, and scalable solutions. - March 07, 2025 - Cenmed
Regenexx® Corporate Program's Dr. Mark Testa Wins the YOU Powered Symposium 2025 Most Influential Clinician in Insurance Award
The YOU Powered Symposium is the leading annual event for "bold benefits trailblazers." It brings together hundreds of benefit professionals, solution providers, clinicians, and employers to combine diverse expertise in an effort to reform the US healthcare system on behalf of every patient. - March 04, 2025 - Regenexx Corporate Program
AI MINDSystems Foundation and GenoBank.io Announce Strategic Partnership at ETHDenver to Advance Decentralized Biobanking and Healthcare Innovation
AI MINDSystems and GenoBank.io partner at ETHDenver to advance decentralized biobanking. Integrating GenoBank.io’s BioNFT™ into the AI MINDSystems Trusted Data Ecosystem™ empowers individuals with control over their biosamples via ‘lockable’ NFTs. This collaboration aims to create secure, privacy-preserving solutions for digital biology, precision health, and research, using blockchain and Web3 technologies. They also plan to launch WISDOM Networks™ for data-driven healthcare transformation. - February 28, 2025 - AI MINDSystems Foundation
Trump-Era Administration Drug Development & Outsourcing Impact Report
How Tariffs and RFK Jr.’s HHS Appointment May Shift Drug Development & Outsourcing - February 27, 2025 - Life Science Strategy Group, LLC
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke Trial
NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in collaboration with the Research Ethics Committee has accepted the amended request for a clinical trial authorisation (CTA). This acceptance will... - February 14, 2025 - NuvOx Therapeutics
Biovenic Scripts a New Chapter to Boom Veterinary Diagnostics
Biovenic, a powerhouse in veterinary research, transforms the way to detect and manage animal diseases, spotlighting innovative animal disease diagnostic solutions that answer the rising demand for exact and precise veterinary diagnostics worldwide. - February 12, 2025 - Biovenic
DDi Released New ViSU eIFU Version for Medical Device Companies
DDi has launched an updated version of its ViSU eIFU platform, designed for medical device manufacturers to transition from traditional paper instructions to electronic formats. The platform supports regulatory compliance with global standards, including the EU MDR and FDA, while providing multi-language accessibility and an enhanced user experience. - January 17, 2025 - DDi LLC
Ales for ALS Achieves $1 Million Milestone and Expands Nationwide
Ales for ALS™, a global initiative uniting craft breweries in the fight against ALS, has reached an extraordinary milestone in 2024: raising $1 million in a single year. Supported by Yakima Chief Hops, this program has seen remarkable growth over its 13-year journey, fueled by the dedication of brewers, sponsors, and a passionate community. - January 06, 2025 - ALS Therapy Development Institute
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
Regenexx Announces Dr. Philippe Hernigou as New Medical Director of Clinical Research
Regenexx®, a leader in regenerative medicine and advanced orthobiologics, is proud to announce that Dr. Philippe Hernigou, a globally recognized expert in autologous cell therapy and musculoskeletal regeneration, has joined the company as its new Medical Director of Clinical Research. Dr. - December 11, 2024 - Regenexx Corporate Program
SeroRepair Announces New Office Location to Support Expansion and Growth
SeroRepair, an eye serum leader in the veterinary industry announces expansion to a new office location for increased operations, customer service, and product development, positioning the company for continued success in the veterinary industry. With an ever-growing demand for high-quality eye care products for small and large animals and a need for increasing efficiency in veterinary practices, SeroRepair has experienced significant growth over the past year. - December 10, 2024 - SeroRepair
Arizona Pharmacy Association Appoints Garet Turner as New CEO
Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona’s pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer. Turner, a seasoned management, membership and fundraising professional will take the helm on January... - December 07, 2024 - Arizona Pharmacy Association
smartDOC: Automated Content Management Now with GenAI
smartDOC – Intelligent Content Platform for Knowledge Organizations. Easily manage regulatory content with streamlined process, leverage automation and deliver faster with their enterprise document / content system. - November 11, 2024 - DDi LLC
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s Testing with BrainCheck and Clarity Health Clinics
Synaps Dx, BrainCheck, and Clarity Health introduce an innovative online Alzheimer's and cognitive health screening tool, accessible from home. Launching in Texas, with nationwide expansion planned, this telehealth solution provides families with a convenient, reliable path to early detection during National Alzheimer’s Disease Awareness Month, reducing the need for in-office visits and empowering proactive cognitive care. - November 04, 2024 - SynapsDx
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.